Ocugen to Host Conference Call on Wednesday, March 4, 2026 at 8:30 A.M. ET to Discuss Business Updates and Fourth Quarter and Full Year 2025 Financial Results

Core Insights - Ocugen, Inc. is set to host a conference call and live webcast on March 4, 2026, at 8:30 a.m. ET to discuss its fourth quarter and full year 2025 financial results and provide a business update [1] - A pre-market earnings announcement will be issued on the same day, with details for participation provided [2] Company Overview - Ocugen, Inc. is a biotechnology leader specializing in gene therapies for blindness diseases, utilizing a modifier gene therapy platform that addresses complex diseases caused by imbalances in multiple gene networks [3] - The company is developing programs for inherited retinal diseases and blindness diseases, including retinitis pigmentosa, Stargardt disease, and geographic atrophy, which affect millions globally [3]